• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• Twitter
• Newsletter

Advertisement

Product › Details

CNS drug

	Next higher product group	pharmaceutical

Record changed: 2022-05-30

Advertisement

More documents for CNS drug

• [1] PharmEnable Ltd.. (5/30/22). "Press Release: PharmEnable Announces Multi-target Collaboration with Denali Therapeutics in Neurodegenerative Disease". Cambridge....
• [2] H. Lundbeck A/S. (4/8/22). "Press Release: Joerg Hornstein to Join Lundbeck as Chief Financial Officer and Head of Corporate Functions". Valby....
• [3] Neuron23 Inc.. (3/30/22). "Press Release: Neuron23 Closes $100 Million Series C Financing Round, Nominates Clinical Candidate for Parkinson's Disease". South San Francisco, CA....
• [4] Argobio S.A.S.. (12/16/21). "Press Release: Argobio and GeneCode Partner on Parkinson’s Disease in Argobio’s First Announced Research Agreement". Paris & Tallinn....
• [5] UCB S.A.. (12/2/21). "Press Release: UCB Announces Global Partnership to Bring Disease-modifying Therapies to People Living with Parkinson’s Disease". Brussels....
• [6] H. Lundbeck A/S. (11/29/21). "Press Release: Lundbeck Announces Changes to Executive Management". Valby....
• [7] Alto Neuroscience. (10/14/21). "Press Release: Alto Neuroscience Emerges with Largest Clinical-Stage Precision Psychiatry Pipeline and $40 Million in Financing". Los Altos, CA....
• [8] Intrance Medical Systems Inc.. (9/20/21). "Press Release: Intrance Medical Systems Raises $8 Million to Support Development of Its Innovative Therapy for Advanced Parkinson’s Disease". Stockholm & New York, NY....
• [9] Vigil Neuroscience, Inc.. (8/18/21). "Press Release: Vigil Neuroscience Completes $90 million Series B Financing to Advance a Pipeline of Microglia-targeted Medicines to Treat Rare and Common Neurodegenerative Diseases". Cambridge, MA....
• [10] Beckley Psytech Ltd.. (8/15/21). "Press Release: Beckley Psytech Completes Oversubscribed $80m (£58m) Fundraise to Develop Portfolio of Psychedelic Medicine Breakthroughs". Oxford....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2022. Made in Germany.